A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

December 31, 2002

Conditions

Pulmonary Disease, Chronic ObstructiveBronchitis, Chronic

Interventions

DRUG

ABX-IL8

Trial Locations (1)

Abgenix, Fremont